BloodStream is an entertaining and informational podcast for the bleeding disorders community. Each week, hemophilia patient Patrick James Lynch and former non-profit director Amy Board are joined by advocacy leaders, medical experts, and other guests to discuss the latest news, scientific advancements, policy initiatives, and so much more. Subscribe wherever you listen, or search BloodStream Podcast on YouTube to catch every episode there. Produced by Believe Limited. Presenting sponsor: Ta ...
…
continue reading
CCHS hemophilia podcast project nick and Sooriya Cover art photo provided by Scott Webb on Unsplash: https://unsplash.com/@scottwebb
…
continue reading
A podcast series sponsored by Pfizer Hemophilia where host Becky VanSant (whose daughter has hemophilia B) speaks with patients, caregivers, and friends in the hemophilia community to talk about a range of important issues.
…
continue reading
What do you do when you’ve achieved your dreams only to realize- your work’s just begun? In January of 2018, Chris Bombardier became the first person with severe hemophilia to complete The Seven Summits. It was the end of an adventure, and the start of a whole new chapter in Chris’s life. From the team behind the documentary Bombardier Blood comes a podcast for adventurers, bleeders, and anyone who’s ever chased a dream. Subscribe to BloodStream Media’s The Final Summit wherever you get your ...
…
continue reading
Reflections on living with hemophilia. Hosted by Michael Bishop.
…
continue reading
MedEdTalks Hematology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. The intended audience for this series is hematologists, hematology nurses (RNs) and nurse practitioners (NPs), oncology RNs, oncology NPs, hemophilia treatment center RNs, hemophilia treatment center NPs, and other health care professionals.
…
continue reading
Ask The Expert from BloodStream Media is a podcast series features hematologists and other healthcare experts answering listener-submitted questions about hemophilia, von willebrand disease, and other inherited bleeding disorders. Learn more at BloodStreamMedia.com. The content contained within Ask The Expert is for informational purposes only. Please consult your health care provider before making any decisions about treatment.
…
continue reading
At Factor Care RX, their commitment to individuals with hemophilia is deeply rooted in empathy and understanding. They recognize the unique challenges and obstacles that come with managing this complex condition and approach each interaction with care and compassion. Whether it's assisting with medication access, navigating insurance complexities, or simply providing a listening ear, Factor Care RX is there every step of the way.
…
continue reading
Acute pain. Chronic pain. Physical pain. Emotional pain. Psychological pain. Spiritual pain. Pain is a part of life, it’s everywhere, and it can be devastating. There are many tools, techniques, and resources for managing it, but what do we actually understand about pain? The Pain Podcast explores this and other pain-related questions. Subscribe now, and tell a friend about us! Produced by BloodStream Media. Presenting Sponsor: Tremeau Pharmaceuticals.
…
continue reading
This is a podcast about plasma donation. As a plasma donor, your contribution to the health and well-being of patients who rely on plasma-derived therapies is invaluable. Plasma saves and improves the lives of people with chronic diseases such as primary immune deficiency, hemophilia, and COVID-19—related conditions. In addition to treating these conditions, plasma is used in emergencies to treat people with burns and other trauma-related injuries. When you donate plasma, you give the gift o ...
…
continue reading
The New FDA Approvals podcast is a weekly podcast that aims to help clinicians, medical writers, and pharmaceutical industry executives stay up to date on the latest FDA approvals. Join Dr. Emma Hitt Nichols each Monday morning for an update on the previous week’s FDA activities.
…
continue reading
i3 Health's mission is to enhance the proficiency of the multidisciplinary health care team by providing evidence-based, fair-balanced CME/NCPD/CPE activities that address identified professional practice gaps and unmet educational needs.
…
continue reading
The Rx Bricks podcast from USMLE-Rx is designed to help you master medical school. Each episode is an audio version of one of our revolutionary Rx Bricks, which are short, high-yield, interactive learning modules. Each week, we present a new audiobrick based on an important basic science topic (e.g., pressure-volume loops) or clinical concept (e.g., ischemic heart disease). Learn more at www.usmle-rx.com
…
continue reading
Earn CME credits while learning about trending clinical topics and research advances from UF Health Shands Hospital experts.
…
continue reading
This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational reso ...
…
continue reading
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
Wait How Do You Spell That? is a rare disease podcast produced by Patient Worthy. We talk about issues affecting people rare and underdiagnosed conditions and interview advocates from across the community. We‘re definitely not doctors, and we can‘t give you medical advice. We‘re just here to chat and learn about the diseases that even doctors can‘t seem to spell. Check out the latest in rare disease news at PatientWorthy.com.
…
continue reading
A podcast about how doctors think. Presented by Figure 1, the knowledge-sharing and collaboration app for physicians and healthcare professionals. Learn more at Figure1.com/ddx
…
continue reading
…
continue reading
Life before, during and after the holocaust with Buchenwald survivor, Melvin Federbush. In hour 5 of this series, he reveals his harrowing experiences while in Nazi occupied Poland. Melvin Federbush was born in Deblin, Poland, July 1923. He attended Cheder and Yeshiva as well as high school. Within eight days of Hitler's invasion of Poland, his parents and nine year old twin sisters were killed during a bombing attack. Melvin was taken prisoner during the Nazi occupation and forced to live i ...
…
continue reading
Podcast by Advanced Medical Strategies
…
continue reading
The official podcast feed of MDedge Hematology-Oncology, part of the Medscape Professional Network. On Thursdays, Dr. David Henry interviews key opinion leaders and rising stars in hematology and oncology. The information in this podcast is provided for informational and educational purposes only.
…
continue reading
Drug Discovery News Talks Science is a podcast where we discuss the latest news in preclinical and translational research. Behind every medical and scientific advancement lies a harrowing story of mystery and discovery. Come with us as we share these stories and connect you to the scientific minds behind them.
…
continue reading
Blood Advances, a Journal of the American Society of Hematology, provides an open international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences. Music for Blood Advances Talks is preformed by the Art Topilow Trio
…
continue reading
I'm Brazilian, I'm funny and I have a lot to say! Or not Maybe you don't care. The fact is that I'm from Brazil, and I'm studying in the US. Doesn't matter what happens I found Happiness and I want to be free. But let's check these interviews and stories, I mean do you have anything better to do?
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hemophilia Film: What We Wished We Could Be
1:05:58
1:05:58
Play later
Play later
Lists
Like
Liked
1:05:58
Patrick has an exclusive conversation with the filmmakers of What We Wished We Could Be, a story about a couple who must sacrifice their dreams in order to confront the consequences of the contaminated blood scandal. Patrick sits down in-studio with screenwriter, Jenna-Louise Hawkins; Director, Luke Shelley; and producer Sophie Stacy about the chal…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges
18:41
18:41
Play later
Play later
Lists
Like
Liked
18:41
This week's VJHemOnc podcast brings you updates in hemophilia from the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually. You hear from experts Omolade Awodu, MBChB, MD, FMCPath, University of Benin, Benin City, Nigeria, who discusses key hemophilia clinical trials in 2024, Rad…
…
continue reading
This week’s episode will be repeating our episode on hemophilias with some updates. We will go over all high yield facts regarding both hemophilia A and B for your boards and end with a little bit about acquired hemophilias.
…
continue reading
Hemophilia is a bleeding disorder resulting from defects in factors of the coagulation cascade. There are two primary types of hemophilia: A and B. Both types of hemophilia are rare, with only a combined frequency of about 1 in 5000 live births. Of the two types, hemophilia A is about four times more common. In the intrinsic arm of the coagulation …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PKD and the Gift of Life, feat. Patient Advocate Valen Keefer
40:10
40:10
Play later
Play later
Lists
Like
Liked
40:10
In this episode of the podcast we speak to Valen Keefer, a professional speaker and patient advocate who was diagnosed with polycystic kidney disease (PKD) at age 10. Valen has faced a number of challenges in her journey, including a double organ transplant, and now inspires other PKD and chronic illness patients by sharing her story. Connect with …
…
continue reading
By UF Health Shands Hospital
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Palliative Care x Dr. Janet Abrahm Part 1
27:44
27:44
Play later
Play later
Lists
Like
Liked
27:44
In Part 1 we discuss how to explain palliative care to patients, pain and anti-emetic management, non-pharmacologic strategies, and current innovations within palliative care. We are so honored to have Dr. Janet Abrahm here with us who is a national leader in the field of palliative care and a professor at Harvard Medical School.…
…
continue reading
In the fed state, glucose is used by almost all the cells in the body to generate energy. But even when we are not fueling it with food, our bodies still run well, such as during sleep. Gluconeogenesis is the process of synthesizing glucose from noncarbohydrate precursors. The major substrates (substances that enzymes act on) are the glucogenic ami…
…
continue reading
Your bleeding disorder doesn’t define you. But it is a part of who you are. And the only way to learn your potential, is to take that first step. Chris talks with Paul Sebastian and Sam Kishyo about their first steps, and learning that the journey can only take you as far as you’re willing to go. The Final Summit was also made possible by support f…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Palliative Care and Oncology: Partners in Patient Care With Richa Thakur, MD, and Janet Abrahm, MD
31:16
31:16
Play later
Play later
Lists
Like
Liked
31:16
In this Fellows Forum podcast episode, Dr. Richa Thakur, Palliative Care Physician and Hematology/Oncology Fellow at Northwell Health, speaks with Dr. Janet Abrahm, one of the founders of the field of palliative care in the United States. Dr. Abrahm shares insights into her career and research in palliative care, including: • How palliative care in…
…
continue reading
Inside the mind of everyone with a bleeding disorder exist two unique mindsets: “Why is this happening to me?” And “If I can take on this, I can take on the world.” Today, Chris talks with chef Mike Hargett and pediatrician Dr. Vyankatesh Pralikar about their unique journeys of facing their own doubts, and coming out stronger on the other side. The…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multicancer Early Detection Technologies: Module 1 - Science Behind Cancer Screening
20:16
20:16
Play later
Play later
Lists
Like
Liked
20:16
Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. Listen now to Module 1 and join Dr. Charles Vega, a distinguished Clinical Professor from UC Irvine, as he explores the cutting-edge realm of multicancer early detection (MCED). Dr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multicancer Early Detection Technologies: Module 2 - Clinical Evidence for MCED Testing
20:13
20:13
Play later
Play later
Lists
Like
Liked
20:13
Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application.Join Dr. Charles Vega in Module 2 of our CME podcast as he delves into the cutting-edge world of multicancer early detection (MCED) tests. With nearly 2 million new cancer cases exp…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multicancer Early Detection Technologies: Module 3 - Implementing MCED Testing in Clinical Practice
23:43
23:43
Play later
Play later
Lists
Like
Liked
23:43
Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application.In Module 3 of our CME podcast, Dr. Charles Vega, Clinical Professor at the University of California, Irvine, will review the latest clinical trial data on MCED tests for gynecologi…
…
continue reading
When you hear the word blood, what do you picture in your mind? Most likely, your brain conjures up an image of thick, red liquid. But what would blood look like if you removed all the red cells? You’d be left with a murky yellowish liquid that would clear up once you removed the white cells and platelets. This lovely, clear, straw-yellow, liquid p…
…
continue reading
Elias Sayour, M.D., discusses the challenges of creating therapeutic cancer vaccines, advantages for mRNA vaccines and how to adapt mRNA to treat patients with cancer.By UF Health Shands Hospital
…
continue reading
![Artwork](/static/images/128pixel.png)
1
ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo vs Adjuvant Nivo for Resectable Stage III Melanoma
10:09
10:09
Play later
Play later
Lists
Like
Liked
10:09
This week’s episode will be discussing updates from ASCO 2024 next with the practice changing NADINA trial presented on the Sunday of ASCO by Dr. Christian Blank during the plenary sessions: A multicenter, randomized, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resect…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inflammation and immune interventions in MDS: targeting STAT, IRAK4, & more
17:29
17:29
Play later
Play later
Lists
Like
Liked
17:29
In myelodysplastic syndromes (MDS), chronic inflammation driven by the innate immune system plays a key role in disease progression. Signal Transducer and Activator of Transcription (STAT) and Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) are critical mediators in this process, where dysregulated signaling leads to aberrant hematopoiesis and t…
…
continue reading
Stories are more than tall tales. They help us relate. They inspire. They educate. They make us feel less alone. Chris talks with Chetan Motiwaras and Patrick James Lynch about the power of story when it comes to bleeding disorders, and how their drive to tell stories led them on their own life’s journey. The Final Summit was also made possible by …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Gene Therapy Reimbursement? We got you covered.
45:23
45:23
Play later
Play later
Lists
Like
Liked
45:23
Patrick survives his first tornado warning and we’ve got Joana Baquero sharing education and advocacy updates on Factor 1 Deficiency and Tammy Black from the Immune Deficiency Foundation. Plus, a new Gene Therapy segment with Jim Kenny, an expert on pharmacy reimbursement. Presenting Sponsor: Takeda, visit bleedingdisorders.com to learn more. Show …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Digital Fingerprint: Accelerating Personalized Drug Discovery and Development at iLoF
12:22
12:22
Play later
Play later
Lists
Like
Liked
12:22
In this episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque sits down with Luis Valente, CEO and Co-Founder of iLoF, a digital health company pioneering a breakthrough AI platform to accelerate the future of personalized drug discovery and development.By i3 Health
…
continue reading
Thiago Beduschi, MD, converses UF Health’s leading liver transplant program, highlighting innovations such as MARS, an artificial liver, and NRP. He explains liver failure, patient support, and how the UF Health program became Florida’s top-ranked liver transplant center as evidenced by the Scientific Registry of Transplant Recipients (SRTR). Dr. B…
…
continue reading
By UF Health Shands Hospital
…
continue reading
By UF Health Shands Hospital
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Updates in the treatment of SCD and thalassemia from EHA 2024: key trial updates, challenges with gene therapies & unmet needs
11:58
11:58
Play later
Play later
Lists
Like
Liked
11:58
Today’s VJHemOnc podcast features experts Rabi Hanna, MD, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, Subarna Chakravorty, MBBS, MRCPCH, FRCPath, PhD, King’s College Hospital NHS Foundation Trust, London, UK, and Ali Taher, MD, PhD, FRCP, American University of Beirut Medical Center, Beirut, Lebanon. They discuss key updates in si…
…
continue reading
Today’s episode is a continuation on fast facts for the IM Board review focusing on the oncology questions. Another 6% of the certifying ABIM test is oncology. While we can’t cover ALL of oncology in just 10 minutes, here are 10 high yield concepts/facts/vignettes you should know walking into your IM Boards.…
…
continue reading
Every story has a beginning. And every journey starts with that first step. Chris talks with Trevor Martin & Destiny Danaye, two budding artists with bleeding disorders who, despite their young age, have lived an entire life before their journey even began. The Final Summit was also made possible by support from Genentech. Visit GenentechHemophilia…
…
continue reading
Ashraf El-Hinnawi, MD, and Georgios Vrakas, MD, MSc, PhD, FRCS, discuss advancements in kidney transplantation at UF Health, highlighting their success in increasing transplant volume and improving outcomes. They emphasize the importance of expanding living-kidney donations, managing waitlists, and exploring future research in xenotransplantation t…
…
continue reading
Ashraf El-Hinnawi, MD, and Georgios Vrakas, MD, MSc, PhD, FRCS, are directors of UF Health’s pancreas transplant program, focusing on performing 15 to 20 transplants annually for selected patients, primarily those with type 1 diabetes and end-stage renal disease. The program emphasizes early referrals, robust patient management, and a multidiscipli…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Power of Resiliency, Feat. Multiple Myeloma Patient Advocate Keisha Hickson
50:02
50:02
Play later
Play later
Lists
Like
Liked
50:02
In this episode of the podcast, we speak to professional speaker and community advocate Keisha Hickson, who was diagnosed with multiple myeloma in 2016. That’s a rare form of cancer that develops in a type of white blood cell called a plasma cell. We discuss navigating a rare cancer diagnosis, adjusting to a new normal and the importance of resilie…
…
continue reading
For many of us, the mountains we climb aren’t physical. They’re spiritual, mental, psychological, and ultimately inspirational. In this season, we’re hearing from people with bleeding disorders from all over the world, who faced their own final summit, and fought for their dreams despite all obstacles. Tune into Season Three of The Final Summit. Co…
…
continue reading
Today’s episode focuses on what you need to know to ace the hematology questions for your 2024 IM boards. 6% of the ABIM exam is hematology which includes erythrocyte, leukocyte and platelet disorders, coagulation disorders, transfusion medicine, and heme malignancies. We discuss some common vignettes & high yield points.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Leqselvi for Alopecia Areata, Femlyv Dissolvable Birth Control, Brineura for Batten Disease, Erzofri for Schizophrenia, Eque-cel for MS, Spravato for TRD, ZW191 Anti-Tumor Agent
9:46
9:46
Play later
Play later
Lists
Like
Liked
9:46
Use AI to Speed up Your Work Flow Ethically and Securely. There are lots of courses on AI out there, but this one is specific only to medical writing and editing. Access the AIMWE course waitlist. https://www.learnamastyle.com/waitlist/ Leqselvi for Alopecia Areata: The FDA has approved deuruxolitinib (Leqselvi) as a first-line treatment for adults…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Unmet treatment needs in MF: managing prefibrotic disease & thrombocytopenia, novel agents & endpoints for clinical trials
16:00
16:00
Play later
Play later
Lists
Like
Liked
16:00
Myelofibrosis (MF) is a chronic myeloproliferative neoplasm (MPN) characterized by bone marrow fibrosis, extramedullary hematopoiesis, and splenomegaly, often resulting in anemia and thrombocytopenia. There are many unmet treatment needs that remain in this space. This week’s podcast features a discussion from the International Workshop on Myelodys…
…
continue reading
Is there a darker side to the extraordinary accomplishments of people with bleeding disorders? Guest segment host, Luke Pembroke, ask just that on the latest I’m Fine, featuring blood brother and Paralympian, Jack Bridge. Also, Patrick and Amy hit up the Chief Patient Officer Summit and got insight on what true patient inclusivity is all about. Plu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Reimagining Surgery Through AI and Computer Vision Technology: Dr. Tamir Wolf and Dr. Waqas Haque
15:42
15:42
Play later
Play later
Lists
Like
Liked
15:42
In this episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque sits down with Dr. Tamir Wolf, Co-Founder and CEO of Theator, a company pioneering next-generation AI and computer vision technology to automatically capture and analyze surgical data in real time to generate actionable insights and improve surgical outcomes.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Additional Advances in Rett Syndrome Research and Clinical Trials With Timothy John Feyma, MD
5:00
5:00
Play later
Play later
Lists
Like
Liked
5:00
Dr. Timothy John Feyma, Pediatric Neurologist at Gillette Children’s Hospital, is currently serving as chair of i3 Health’s CME/NCPD activity, Exploring Novel Treatments for Rett Syndrome. With new developments in the field occurring over recent months, Dr. Feyma sat down with us again to share new updates in treatment and management of Rett syndro…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Voquenza for GERD, ADI-270 for Clear Cell Renal Cell Carcinoma, Lomecel-B in AD, ART26.12 for Chemotherapy-Induced Peripheral Neuropathy, Test for Candida auris, Botensilimab/balstilimab in mCRC
10:20
10:20
Play later
Play later
Lists
Like
Liked
10:20
Visit learnAMAstyle.com to uplevel your writing and editing skills with free downloads on medical writing and editing. The FDA has approved vonoprazan (Voquenza) for treating non-erosive gastroesophageal reflux disease (GERD) in adults. Vonoprazan is an oral potassium-competitive acid blocker (PCAB) already approved for erosive esophagitis and Heli…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The role of BTK inhibitors in MCL, ongoing trials & future outlooks: updates from EHA 2024
12:13
12:13
Play later
Play later
Lists
Like
Liked
12:13
The introduction of Bruton's tyrosine kinase (BTK) inhibitors into the treatment landscape for mantle cell lymphoma (MCL) has transformed the field and provided patients with a promising therapeutic option. In this podcast, you will hear from leading experts who discuss the value of these agents in MCL, sharing updates from EHA 2024. Tune in as Man…
…
continue reading
This week’s episode will be focusing on infusion reactions - one of the most common calls we get as heme/onc fellows and high yield facts for new fellows as well as boards. We will go over the important details on mechanisms of infusion reaction, class of drugs that most commonly cause infusion reactions, treatment for infusion reactions, and when/…
…
continue reading
Pain is a sensation that warns of potential injury and alerts the person to avoid or treat it. For example, if you touch a hot object, you will feel pain and immediately remove your hand from that object, protecting your hand from further damage. As much as pain can burden and torment, ultimately it is an essential part of our bodies’ mechanisms of…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Blincyto for B-ALL, Zorvye for Atopic Dermatitis, Vabysmo Pre-filled Syringe, OX124 for Opioid Overdose Reversal, Voquezna for GERD
9:59
9:59
Play later
Play later
Lists
Like
Liked
9:59
Visit learnAMAstyle.com for free downloads in writing in medicine and the life sciences. The FDA has approved blinatumomab (Blincyto) for treating adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in the consolidation phase. This bispecific T-c…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Novel developments in lower-risk MDS & important practical considerations when treating patients
51:42
51:42
Play later
Play later
Lists
Like
Liked
51:42
In today’s VJHemOnc podcast, we will be sharing novel developments in lower-risk myelodysplastic syndromes (LR-MDS) and important practical considerations when treating patients. You will hear from experts Amer Zeidan, MBBS, Yale University and Yale Cancer Center, New Haven, CT, Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook …
…
continue reading
This week’s episode will be focusing on common topics both for new fellows & residents. We will go over the important details on some clinically important oncologic emergencies including brain metastases, hypercalcemia, cord compression and SVC syndrome.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Epilepsy and Unmet Need, feat. The LGS Foundation and Ovid Therapeutics
42:39
42:39
Play later
Play later
Lists
Like
Liked
42:39
This episode's guests include Dr. Tracy Dixon-Salazar, Executive Director for the Lennox-Gastaut Syndrome (LGS) Foundation, as well as Meg Alexander, Chief Strategy Officer of Ovid Therapeutics. We discuss the treatment landscape for seizure disorders such as LGS and why further research and investment is crucial. Connect with the LGS Foundation: W…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Clinical Trials, Caregiving, and NEW MUSIC!?
43:37
43:37
Play later
Play later
Lists
Like
Liked
43:37
On this episode, Patrick James Lynch honors the late Neil Frick, Senior VP for Medical Programs at the National Bleeding Disorders Foundation, recognizing his invaluable two-decade contribution to the bleeding disorders community. We also discuss hemophilia B gene therapy with Dr. Mark Redding, focusing on unique clinical trial designs and the role…
…
continue reading
As we eat, our gastrointestinal (GI) system releases a host of both local and distant regulators to control the process of digestion. We will begin with the primary hormones, then cover some of the secondary hormones, and lastly discuss how our body senses its intraluminal contents and then subsequently integrates all of the various stimuli it rece…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Practice-Changing Advances in the Management of Hemophilia
42:37
42:37
Play later
Play later
Lists
Like
Liked
42:37
In this podcast, hear expert perspectives on practice-changing advances in the treatment and personalized management of patients with hemophilia from Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology/Oncology, and Professor of Pediatrics at Keck School of Medicine of USC; and Dr. Jennifer Davila, Co…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer
12:26
12:26
Play later
Play later
Lists
Like
Liked
12:26
This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC).
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Updates on the use of BCMA-targeting bispecific antibodies in R/R multiple myeloma: insights from EHA & ASCO 2024
16:18
16:18
Play later
Play later
Lists
Like
Liked
16:18
BCMA-targeting bispecific antibodies treat multiple myeloma by binding to BCMA on malignant plasma cells and directing T-cells to initiate targeted cell killing. This podcast provides updates on the use of BCMA-targeting bispecific antibodies in relapsed/refractory (R/R) multiple myeloma from the 2024 American Society of Clinical Oncology (ASCO) Me…
…
continue reading